RIGL Rigel Pharmaceuticals Inc

$32.92 -1.44%

Healthcare · Pharmaceutical Preparations

Rigel Pharmaceuticals Inc (RIGL) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $609 million. Shares last traded at $32.92, 36.8% below their 52-week high. Over the past year the stock is up 71.6%. RIGL trades at a price-to-earnings ratio of 1.66, below the Pharmaceutical Preparations median of 16.82. Net profit margin is 124.7%, above the peer median of -0.1%. Revenue grew 64.1% year over year.

Market Cap

$609M

Shares Out

18.5M

EPS (TTM)

$10.36

P/E Ratio

3.18

P/S Ratio

2.07

P/B Ratio

1.52

Dividend / Share

—

Dividend Yield

—

52-Week High

$52.05

52-Week Low

$18.14

Volume

24,126

Avg Vol (3m)

14,942.81

Performance

+2.70%

+16.26%

+26.52%

-21.65%

YTD

-21.26%

+71.64%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

61.14

SMA (50)

$30.23

SMA (200)

$34.08

Price vs SMA50

+8.90%

Price vs SMA200

-3.40%

ATR (14)

$1.51

Financials

Revenue

$294M

Net Income

$367M

Gross Margin

—

Operating Margin

42.6%

Net Margin

124.7%

Return on Equity

91.8%

Return on Assets

72.7%

Current Ratio

2.62

Debt / Equity

0.11

Revenue Growth (YoY)

+64.1%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$0.44	2026-05-05
FY 2025	$19.48	2026-03-03
Q3 2025	$5.38	2025-11-04
Q2 2025	$3.91	2025-08-05
Q1 2026	$0.63	2026-05-05
FY 2025	$0.99	2026-03-03

Full earnings history →

Pharmaceutical Preparations peers

RIGL vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

1.66 / 16.82 med

-90% discount

P/S vs peers

2.07 / 3.54 med

-41% discount

Net margin vs peers

124.7% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.